The U.S. advanced wound care market size was estimated at USD 4.58 billion in 2022 and is expected to surpass around USD 11.77 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 9.9% during the forecast period 2023 to 2032.
Key Pointers:
U.S. Advanced Wound Care Market Report Scope
Report Coverage |
Details |
Market Size in 2023 |
USD 5.03 Billion |
Market Size by 2032 |
USD 11.77 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 9.9% |
Base year |
2022 |
Forecast period |
2023 to 2032 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, Application, End-use |
Key companies profiled |
Smith & Nephew PLC; Mölnlycke Health Care AB; Acelity; ConvaTec Group PLC; Johnson & Johnson; Baxter; Coloplast Corp.; Medtronic; 3M; Medline Industries; Inc.; Integra LifeSciences |
The need for advanced wound care products is increasing owing to the growing incidence of chronic wounds, increasing demand for reducing hospital stay, and the rising number of surgeries in the U.S.
Rising incidence of chronic diseases such as diabetes, cancer, and other autoimmune disorders is anticipated to increase the incidence rate of chronic wounds in the U.S. Factors such as antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption is contributing to rising prevalence of non-communicable diseases. According to the National Diabetes Statistics Report 2017, published by the CDC, more than 100.0 million people in the U.S. were living with diabetes or prediabetes conditions.
Cancer is also considered to be a healthcare burden, as it is one of the leading causes of death in the country. According to estimates from Cancer Organization, in 2018, cancer was the second leading cause of death and about 1,735,350 new cancer cases were registered in the U.S. In addition, nearly 4,700 new cases of cancer are diagnosed each day in the country.
The rising number of surgeries is also one of the major factors driving the market growth. The number of surgeries is increasing owing to the rising prevalence of chronic conditions. Wound care products, thus, are increasingly being used to prevent surgical site infections. Most surgical wounds, post-cancer surgery, are relatively larger in size and deep, releasing exudates that require regular management. Advanced products such as a hydrogel, alginate, and foam help manage large wounds, thereby significantly reducing the risk of infection. Thus, the rising incidence of chronic diseases is expected to boost demand for wound care products, thus aiding growth.
The rising number of surgical procedures is also expected to boost demand for home healthcare services. According to the American Society for Metabolic and Bariatric Surgery in 2022, the number of people underwent sleeve gastrectomy increased by 11.05% from 2018 to 2023 in the U.S. Patients undergoing surgeries are required to stay at hospitals for a longer period of time; thus, most patients prefer home healthcare services over hospital stays. These services offer several advantages such as personal care and home-delivered meals, among others. Therefore, these factors are likely to boost demand for home healthcare services, thereby fueling market growth during the forecast period.
Some of the prominent players in the U.S. advanced wound care Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. advanced wound care market.
By Product
By Application
By End-use